What is the recommended dosing schedule for paroxetine, including starting dose, titration, maximum dose, and tapering for adults and elderly patients?

Paroxetine Dosing Recommendations

For adults, start paroxetine at 20 mg once daily in the morning, which is both the starting and minimum effective dose for most patients; increase by 10 mg increments at weekly intervals if needed, up to a maximum of 50 mg/day, while elderly patients should start at 10 mg/day with a maximum of 40 mg/day. 1

Standard Adult Dosing

Starting Dose

• 20 mg once daily (morning, with or without food) 1
• This is the established effective dose for most indications including major depressive disorder, generalized anxiety disorder, PTSD, and social anxiety disorder 1
• For panic disorder and OCD, 40-60 mg/day may be more effective, but start at 20 mg 1

Titration Schedule

• Increase by 10 mg increments at minimum weekly intervals if inadequate response after 1-3 weeks 1, 2
• Do not increase more frequently than weekly due to saturable metabolism and nonlinear kinetics 1
• Maximum dose: 50 mg/day 3, 1

Maintenance

• Most patients respond optimally to 20 mg/day 2
• For OCD: 40-60 mg/day often required 1
• For panic disorder: mean effective dose approximately 40 mg/day 1

Elderly and Special Populations

Elderly Patients (≥65 years)

• Start at 10 mg/day 3, 1
• Maximum dose: 40 mg/day 3, 1, 2
• Plasma concentrations are 70-80% higher than in younger adults due to reduced clearance 1
• Despite higher concentrations, dose reduction is recommended for safety, though efficacy studies don't necessarily advocate lower doses 4

Renal or Hepatic Impairment

• Start at 10 mg/day 1
• Severe renal impairment (CrCl <30 mL/min): 4-fold increase in plasma concentrations 1
• Moderate renal impairment (CrCl 30-60 mL/min) or hepatic impairment: 2-fold increase 1
• Maximum: 40 mg/day 1

Discontinuation and Tapering

Gradual dose reduction is essential to minimize discontinuation symptoms—never stop abruptly, especially at doses above 20 mg/day. 1, 5

Tapering Strategy

• Gradual reduction preferred over abrupt cessation 1
• For patients on >20 mg/day: taper more slowly 5
• If intolerable symptoms occur during taper, resume previous dose and decrease more gradually 1
• Discontinuation symptoms include marked sleep disturbances, dizziness, and other withdrawal effects 5
• Monitor for 2 weeks after discontinuation 1

High-Dose Discontinuation

For patients on higher doses (40-60 mg/day), a more gradual tapering strategy is specifically recommended due to higher steady-state concentrations 6

Critical Considerations

Pharmacokinetic Factors

• Half-life: approximately 21 hours at steady state 1
• Nonlinear kinetics due to saturable CYP2D6 metabolism—doubling the dose more than doubles plasma levels 1
• Steady state achieved after multiple doses, with concentrations 70-80% higher in elderly 1

Drug Interactions

• 14-day washout required when switching to/from MAOIs 1
• If urgent treatment with linezolid or methylene blue needed, stop paroxetine and wait 24 hours after last dose of these agents before resuming 1

Common Pitfalls to Avoid

• Do not use paroxetine as first-line in elderly due to anticholinergic effects—prefer sertraline, citalopram, or escitalopram 3
• Do not increase dose more frequently than weekly intervals 1
• Do not abruptly discontinue, especially at doses >20 mg/day 5
• Do not exceed 40 mg/day in elderly or those with renal/hepatic impairment 1

Pregnancy Considerations

When treating pregnant women in third trimester, consider tapering paroxetine due to neonatal complications requiring prolonged hospitalization 1